AMYRIS, INC.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000136591623000060 Filed on May 10, 2023

Income Statement

Concept	2023 Q2	2023 Q1

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments		$11.25M
YoY Change		-96.09%
Cash & Equivalents		$11.20M
Short-Term Investments
Other Short-Term Assets		$5.012M
YoY Change		35.53%
Inventory		$109.0M
Prepaid Expenses		$17.23M
Receivables		$85.23M
Other Receivables		$7.262M
Total Short-Term Assets		$243.7M
YoY Change		-48.26%
LONG-TERM ASSETS
Property, Plant & Equipment		$189.6M
YoY Change		51.4%
Goodwill		$50.46M
YoY Change		-62.9%
Intangibles		$45.06M
YoY Change		-19.67%
Long-Term Investments		$3.000M
YoY Change		-68.92%
Other Assets		$13.66M
YoY Change		-41.95%
Total Long-Term Assets		$436.0M
YoY Change		1.99%
TOTAL ASSETS
Total Short-Term Assets		$243.7M
Total Long-Term Assets		$436.0M
Total Assets		$679.7M
YoY Change		-24.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$200.1M
YoY Change		126.6%
Accrued Expenses		$81.07M
YoY Change		0.64%
Deferred Revenue		$33.00K
YoY Change		-97.88%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due		$1.968M
YoY Change		86.54%
Total Short-Term Liabilities		$470.8M
YoY Change		76.85%
LONG-TERM LIABILITIES
Long-Term Debt		$675.9M
YoY Change		0.57%
Other Long-Term Liabilities		$5.725M
YoY Change		64.04%
Total Long-Term Liabilities		$681.6M
YoY Change		0.9%
TOTAL LIABILITIES
Total Short-Term Liabilities		$470.8M
Total Long-Term Liabilities		$681.6M
Total Liabilities		$1.328B
YoY Change		29.62%
SHAREHOLDERS EQUITY
Retained Earnings		-$3.100B
YoY Change		26.07%
Common Stock		$37.00K
YoY Change		15.63%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		-$664.4M
YoY Change
Total Liabilities & Shareholders Equity		$679.7M
YoY Change		-24.35%

Cashflow Statement

Concept	2023 Q2	2023 Q1

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001365916
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2021	us-gaap	Accounting Standards Update Extensible List AccountingStandardsUpdateExtensibleList	http://fasb.org/us-gaap/2022#AccountingStandardsUpdate202006Member
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-34885
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	AMYRIS, INC.
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	55-0856151
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	5885 Hollis Street
CY2023Q1	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Emeryville
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94608
CY2023Q1	dei	City Area Code CityAreaCode	510
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	450-0761
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	AMRS
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	false
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	369385614	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11245000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64437000	usd
CY2023Q1	us-gaap	Restricted Cash Current RestrictedCashCurrent	71000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	71000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	997000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	995000	usd
CY2023Q1	amrs	Accounts Receivable Net Current Excluding Related Parties AccountsReceivableNetCurrentExcludingRelatedParties	36842000	usd
CY2022Q4	amrs	Accounts Receivable Net Current Excluding Related Parties AccountsReceivableNetCurrentExcludingRelatedParties	45775000	usd
CY2023Q1	amrs	Accounts Receivable Allowance For Credit Loss Related Parties Current AccountsReceivableAllowanceForCreditLossRelatedPartiesCurrent	0	usd
CY2022Q4	amrs	Accounts Receivable Allowance For Credit Loss Related Parties Current AccountsReceivableAllowanceForCreditLossRelatedPartiesCurrent	0	usd
CY2023Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	10836000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	6608000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3872000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	806000	usd
CY2023Q1	amrs	Contract With Customer Asset Related Party After Allowance For Credit Loss Current ContractWithCustomerAssetRelatedPartyAfterAllowanceForCreditLossCurrent	33679000	usd
CY2022Q4	amrs	Contract With Customer Asset Related Party After Allowance For Credit Loss Current ContractWithCustomerAssetRelatedPartyAfterAllowanceForCreditLossCurrent	36638000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	109021000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	111880000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38095000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	40146000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	243661000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	306361000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	189645000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	182224000	usd
CY2023Q1	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6135000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	6090000	usd
CY2023Q1	amrs	Recoverable Taxes On Purchase Of Fixed Assets RecoverableTaxesOnPurchaseOfFixedAssets	30189000	usd
CY2022Q4	amrs	Recoverable Taxes On Purchase Of Fixed Assets RecoverableTaxesOnPurchaseOfFixedAssets	29472000	usd
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	147000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	152000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	100721000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	97216000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	50456000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	142575000	usd
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	45063000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	46938000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13662000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13904000	usd
CY2023Q1	us-gaap	Assets Assets	679679000	usd
CY2022Q4	us-gaap	Assets Assets	824932000	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	200067000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	190486000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81068000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	73565000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	14000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	13000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2484000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2255000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	33000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	26000	usd
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	1968000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	1916000	usd
CY2023Q1	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	185160000	usd
CY2022Q4	us-gaap	Due To Related Parties Current DueToRelatedPartiesCurrent	118886000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	470794000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	387147000	usd
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	675855000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	674891000	usd
CY2023Q1	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	77962000	usd
CY2022Q4	us-gaap	Due To Related Parties Noncurrent DueToRelatedPartiesNoncurrent	97350000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	44000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	48000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	90986000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	86195000	usd
CY2023Q1	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	4140000	usd
CY2022Q4	us-gaap	Derivative Liabilities Noncurrent DerivativeLiabilitiesNoncurrent	5403000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	2241000	usd
CY2022Q4	us-gaap	Business Combination Contingent Consideration Liability Noncurrent BusinessCombinationContingentConsiderationLiabilityNoncurrent	34555000	usd
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	5725000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7053000	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1327747000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1292642000	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5000000	usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	26058000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	28892000	usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	550000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	368524240	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	368524240	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	364745266	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	364745266	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	37000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	36000	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2465802000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2455567000	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-56682000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-64114000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3073520000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2880178000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-664363000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-488689000	usd
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-9763000	usd
CY2022Q4	us-gaap	Minority Interest MinorityInterest	-12913000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-674126000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-501602000	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	679679000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	824932000	usd
CY2023Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	9711000	usd
CY2022Q1	us-gaap	Revenue From Related Parties RevenueFromRelatedParties	15228000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	56083000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	57709000	usd
CY2023Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	51081000	usd
CY2022Q1	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	48995000	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26765000	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	26358000	usd
CY2023Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	95870000	usd
CY2022Q1	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	106916000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-28503000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	us-gaap	Restructuring Charges RestructuringCharges	1013000	usd
CY2022Q1	us-gaap	Restructuring Charges RestructuringCharges	0	usd
CY2023Q1	amrs	Impairment Of Other Assets ImpairmentOfOtherAssets	95386000	usd
CY2022Q1	amrs	Impairment Of Other Assets ImpairmentOfOtherAssets	0	usd
CY2023Q1	us-gaap	Costs And Expenses CostsAndExpenses	241612000	usd
CY2022Q1	us-gaap	Costs And Expenses CostsAndExpenses	182269000	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-185529000	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-124560000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	12983000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	5263000	usd
CY2023Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1263000	usd
CY2022Q1	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	1815000	usd
CY2023Q1	amrs	Debt Changes In Fair Value Gain Loss DebtChangesInFairValueGainLoss	-4854000	usd
CY2022Q1	amrs	Debt Changes In Fair Value Gain Loss DebtChangesInFairValueGainLoss	20796000	usd
CY2023Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-533000	usd
CY2022Q1	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-3052000	usd
CY2023Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-17107000	usd
CY2022Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14296000	usd
CY2023Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-202636000	usd
CY2022Q1	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-110264000	usd
CY2023Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-860000	usd
CY2022Q1	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-820000	usd
CY2023Q1	amrs	Gain Loss From Investment In Affiliates GainLossFromInvestmentInAffiliates	0	usd
CY2022Q1	amrs	Gain Loss From Investment In Affiliates GainLossFromInvestmentInAffiliates	-789000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-201776000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-110233000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8434000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2928000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-193342000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-107305000	usd
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	365603738	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	312896452	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	365603738	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	323711682	shares
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-201776000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-110233000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	7431000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	15286000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-194345000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-94947000	usd
CY2023Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-8434000	usd
CY2022Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-2928000	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-185911000	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-92019000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-501602000	usd
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5000000	usd
CY2022Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	28892000	usd
CY2023Q1	us-gaap	Reclassifications Of Temporary To Permanent Equity ReclassificationsOfTemporaryToPermanentEquity	5000000	usd
CY2023Q1	amrs	Temporary Equity Reclassifications Of Temporary And Permanent Equity TemporaryEquityReclassificationsOfTemporaryAndPermanentEquity	5000000	usd
CY2023Q1	us-gaap	Noncontrolling Interest Increase From Subsidiary Equity Issuance NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance	4650000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-5000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	3085000	usd
CY2023Q1	amrs	Adjustments To Additional Paid In Capital Modification Of Warrants In Connection With Loan AdjustmentsToAdditionalPaidInCapitalModificationOfWarrantsInConnectionWithLoan	471000	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	5785000	usd
CY2023Q1	amrs	Adjustments To Additional Paid In Capital Noncontrolling Interest Write Off AdjustmentsToAdditionalPaidInCapitalNoncontrollingInterestWriteOff	4100000	usd
CY2023Q1	amrs	Temporary Equity Decrease Due To Write Off TemporaryEquityDecreaseDueToWriteOff	4100000	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	7432000	usd
CY2023Q1	amrs	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingTemporaryEquity	-194842000	usd
CY2023Q1	us-gaap	Temporary Equity Net Income TemporaryEquityNetIncome	-6934000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-674126000	usd
CY2023Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	0	usd
CY2023Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	26058000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	245688000	usd
CY2021Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5000000	usd
CY2021Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	28520000	usd
CY2022Q1	us-gaap	Noncontrolling Interest Increase From Business Combination NoncontrollingInterestIncreaseFromBusinessCombination	155000	usd
CY2022Q1	amrs	Redeemable Noncontrolling Interest Increase From Business Combinations RedeemableNoncontrollingInterestIncreaseFromBusinessCombinations	2917000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-3000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	33094000	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	98000	usd
CY2022Q1	amrs	Adjustments To Additional Paid In Capital Warrant Exercised AdjustmentsToAdditionalPaidInCapitalWarrantExercised	3994000	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11588000	usd
CY2022Q1	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	15286000	usd
CY2022Q1	amrs	Net Income Loss Including Portion Attributable To Noncontrolling Interest Excluding Temporary Equity NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestExcludingTemporaryEquity	-110233000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-162314000	usd
CY2022Q1	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	5000000	usd
CY2022Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	31437000	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-201776000	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-110233000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5068000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	962000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1325000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	892000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	6855000	usd
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	754000	usd
CY2023Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	4527000	usd
CY2022Q1	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2400000	usd
CY2023Q1	amrs	Debt Instrument Gain Loss On Change In Fair Value DebtInstrumentGainLossOnChangeInFairValue	-4854000	usd
CY2022Q1	amrs	Debt Instrument Gain Loss On Change In Fair Value DebtInstrumentGainLossOnChangeInFairValue	20796000	usd
CY2023Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1263000	usd
CY2022Q1	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	1815000	usd
CY2023Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-661000	usd
CY2022Q1	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1519000	usd
CY2023Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	-28503000	usd
CY2022Q1	us-gaap	Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1 BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1	0	usd
CY2023Q1	amrs	Gain Loss From Investment In Affiliate Noncash GainLossFromInvestmentInAffiliateNoncash	0	usd
CY2022Q1	amrs	Gain Loss From Investment In Affiliate Noncash GainLossFromInvestmentInAffiliateNoncash	-789000	usd
CY2023Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	95386000	usd
CY2022Q1	us-gaap	Goodwill And Intangible Asset Impairment GoodwillAndIntangibleAssetImpairment	0	usd
CY2023Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-8000	usd
CY2022Q1	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	0	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	5785000	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	11588000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-5288000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1554000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	102000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	8472000	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2904000	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5001000	usd
CY2023Q1	amrs	Increase Decrease Of Recoverable Taxes On Purchase Of Fixed Assets IncreaseDecreaseOfRecoverableTaxesOnPurchaseOfFixedAssets	-2156000	usd
CY2022Q1	amrs	Increase Decrease Of Recoverable Taxes On Purchase Of Fixed Assets IncreaseDecreaseOfRecoverableTaxesOnPurchaseOfFixedAssets	23881000	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	9112000	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	5007000	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	3081000	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	6026000	usd
CY2023Q1	amrs	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-5375000	usd
CY2022Q1	amrs	Increase Decrease In Lease Liabilities IncreaseDecreaseInLeaseLiabilities	-9658000	usd
CY2023Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	8000	usd
CY2022Q1	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-969000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-90001000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-152442000	usd
CY2023Q1	amrs	Payments To Acquire Property Plant And Equipment Net Of Disposals PaymentsToAcquirePropertyPlantAndEquipmentNetOfDisposals	4815000	usd
CY2022Q1	amrs	Payments To Acquire Property Plant And Equipment Net Of Disposals PaymentsToAcquirePropertyPlantAndEquipmentNetOfDisposals	33751000	usd
CY2023Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	usd
CY2022Q1	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	13535000	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-4815000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-47286000	usd
CY2023Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	4650000	usd
CY2022Q1	us-gaap	Proceeds From Contributed Capital ProceedsFromContributedCapital	0	usd
CY2023Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5000	usd
CY2022Q1	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3000	usd
CY2023Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	3000	usd
CY2022Q1	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	131000	usd
CY2023Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
CY2022Q1	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	98000	usd
CY2023Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	0	usd
CY2022Q1	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	3994000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	36972000	usd
CY2022Q1	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	0	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	41614000	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	3958000	usd
CY2023Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	55000	usd
CY2022Q1	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	169000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-53147000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-195601000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	70598000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	488312000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17451000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	292711000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11245000	usd
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	287886000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	71000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	174000	usd
CY2023Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	6135000	usd
CY2022Q1	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	4651000	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	17451000	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	292711000	usd
CY2023Q1	us-gaap	Interest Paid Net InterestPaidNet	1567000	usd
CY2022Q1	us-gaap	Interest Paid Net InterestPaidNet	52000	usd
CY2023Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	262000	usd
CY2022Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	100000	usd
CY2023Q1	amrs	Capitalized Interest CapitalizedInterest	1427000	usd
CY2022Q1	amrs	Capitalized Interest CapitalizedInterest	0	usd
CY2023Q1	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	0	usd
CY2022Q1	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	18417000	usd
CY2023Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	0	usd
CY2022Q1	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	27165000	usd
CY2023Q1	amrs	Common Stock Issued As Purchase Consideration In Business Combinations CommonStockIssuedAsPurchaseConsiderationInBusinessCombinations	0	usd
CY2022Q1	amrs	Common Stock Issued As Purchase Consideration In Business Combinations CommonStockIssuedAsPurchaseConsiderationInBusinessCombinations	33094000	usd
CY2023Q1	amrs	Stock Issued Acquisitions Contingent Consideration Liability StockIssuedAcquisitionsContingentConsiderationLiability	3084000	usd
CY2022Q1	amrs	Stock Issued Acquisitions Contingent Consideration Liability StockIssuedAcquisitionsContingentConsiderationLiability	0	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	7666000	usd
CY2023Q1	amrs	Measurement Adjustment Of Contingently Redeemable Noncontrolling Interest MeasurementAdjustmentOfContingentlyRedeemableNoncontrollingInterest	4100000	usd
CY2022Q1	amrs	Measurement Adjustment Of Contingently Redeemable Noncontrolling Interest MeasurementAdjustmentOfContingentlyRedeemableNoncontrollingInterest	0	usd
CY2023Q1	amrs	Noncash Or Part Noncash Acquisition Noncontrolling Interest Fair Value NoncashOrPartNoncashAcquisitionNoncontrollingInterestFairValue	0	usd
CY2022Q1	amrs	Noncash Or Part Noncash Acquisition Noncontrolling Interest Fair Value NoncashOrPartNoncashAcquisitionNoncontrollingInterestFairValue	3072000	usd
CY2023Q1	amrs	Remeasurement Of Operating Lease Right Of Use Asset And Operating Lease Liability RemeasurementOfOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability	1062000	usd
CY2022Q1	amrs	Remeasurement Of Operating Lease Right Of Use Asset And Operating Lease Liability RemeasurementOfOperatingLeaseRightOfUseAssetAndOperatingLeaseLiability	0	usd
CY2023Q1	amrs	Acquisition Of Property Plant And Equipment Under Accounts Payable Accrued Liabilities And Notes Payable AcquisitionOfPropertyPlantAndEquipmentUnderAccountsPayableAccruedLiabilitiesAndNotesPayable	5234000	usd
CY2022Q1	amrs	Acquisition Of Property Plant And Equipment Under Accounts Payable Accrued Liabilities And Notes Payable AcquisitionOfPropertyPlantAndEquipmentUnderAccountsPayableAccruedLiabilitiesAndNotesPayable	4995000	usd
CY2023Q1	amrs	Modification Of Warrants In Connection With Loan ModificationOfWarrantsInConnectionWithLoan	471000	usd
CY2022Q1	amrs	Modification Of Warrants In Connection With Loan ModificationOfWarrantsInConnectionWithLoan	0	usd
CY2022	amrs	Number Of Consumer Brands NumberOfConsumerBrands	8	brand
CY2023Q1	amrs	Working Capital WorkingCapital	227100000	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3100000000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11200000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	962000000	usd
CY2023Q1	amrs	Long Term Debt Current Maturities Including Due To Related Parties Principal LongTermDebtCurrentMaturitiesIncludingDueToRelatedPartiesPrincipal	188800000	usd
CY2023Q1	us-gaap	Debt Instrument Increase Decrease For Period Net DebtInstrumentIncreaseDecreaseForPeriodNet	60100000	usd
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11200000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	64400000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates and Judgements</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates, judgements and assumptions that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, and such differences may be material to the condensed consolidated financial statements. Significant estimates and judgements used in these consolidated financial statements are discussed in the relevant accounting policies below or specifically discussed in the Notes to Consolidated Financial Statements where such transactions are disclosed.</span></div>
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	995000	usd
CY2023Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	2000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	997000	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	945000	usd
CY2022Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	20000	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	0	usd
CY2022Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	965000	usd
CY2023Q1	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	4183000	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	41211000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	43043000	usd
CY2023Q1	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	14749000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	8028000	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	53061000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	60809000	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	109021000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	111880000	usd
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	17233000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	18849000	usd
CY2023Q1	amrs	Non Inventory Production Supplies NonInventoryProductionSupplies	8588000	usd
CY2022Q4	amrs	Non Inventory Production Supplies NonInventoryProductionSupplies	8138000	usd
CY2022Q1	us-gaap	Lease Cost LeaseCost	300000	usd
CY2022Q4	us-gaap	Nontrade Receivables Current NontradeReceivablesCurrent	6871000	usd
CY2023Q1	amrs	Recoverable Taxes From Brazilian Government Entities RecoverableTaxesFromBrazilianGovernmentEntities	3079000	usd
CY2022Q4	amrs	Recoverable Taxes From Brazilian Government Entities RecoverableTaxesFromBrazilianGovernmentEntities	870000	usd
CY2023Q1	us-gaap	Other Assets Current OtherAssetsCurrent	5012000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	5418000	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	38095000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	40146000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	297959000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	285575000	usd
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	108314000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	103351000	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	189645000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	182224000	usd
CY2023Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	4527000	usd
CY2022Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2400000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	142575000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	131259000	usd
CY2023Q1	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	0	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	22231000	usd
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	94351000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q1	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	2232000	usd
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-10915000	usd
CY2023Q1	us-gaap	Goodwill Goodwill	50456000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	142575000	usd
CY2023Q1	amrs	Goodwill Impairment Strategic Plan Term GoodwillImpairmentStrategicPlanTerm	P3Y
CY2023Q1	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	94400000	usd
CY2022	us-gaap	Finitelived Intangible Assets Acquired1 FinitelivedIntangibleAssetsAcquired1	14600000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	50728000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	5665000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45063000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	51296000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	4358000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	46938000	usd
CY2023Q1	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1000000	usd
CY2023Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1300000	usd
CY2022Q1	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	900000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear	3939000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	6323000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	6433000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	6161000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	5262000	usd
CY2023Q1	amrs	Finite Lived Intangible Asset Expected Amortization After Year Four FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour	16945000	usd
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	45063000	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	100700000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	97200000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	93500000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	88500000	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	6900000	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	3700000	usd
CY2023Q1	us-gaap	Lease Cost LeaseCost	600000	usd
CY2023Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	4620000	usd
CY2022Q1	us-gaap	Operating Lease Payments OperatingLeasePayments	3045000	usd
CY2023Q1	amrs	Right Of Use Asset Obtained In Exchange For Operating Lease Liability And Adoption Of New Accounting Principle RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityAndAdoptionOfNewAccountingPrinciple	0	usd
CY2022Q1	amrs	Right Of Use Asset Obtained In Exchange For Operating Lease Liability And Adoption Of New Accounting Principle RightOfUseAssetObtainedInExchangeForOperatingLeaseLiabilityAndAdoptionOfNewAccountingPrinciple	18759000	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P11Y2M12D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y8M12D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.226
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.190
CY2023Q1	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	1600000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Accumulated Amortization FinanceLeaseRightOfUseAssetAccumulatedAmortization	1600000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Remainder Of Fiscal Year FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear	16000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	14989000	usd
CY2023Q1	amrs	Lease Liability Payments Remainder Of Fiscal Year LeaseLiabilityPaymentsRemainderOfFiscalYear	15005000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	21000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	23808000	usd
CY2023Q1	amrs	Lease Liability Payments Year One LeaseLiabilityPaymentsYearOne	23829000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	21000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	23361000	usd
CY2023Q1	amrs	Lease Liability Payments Due Year Two LeaseLiabilityPaymentsDueYearTwo	23382000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	16000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	24649000	usd
CY2023Q1	amrs	Lease Liability Payments Due Year Three LeaseLiabilityPaymentsDueYearThree	24665000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	25888000	usd
CY2023Q1	amrs	Lease Liability Payments Due Year Four LeaseLiabilityPaymentsDueYearFour	25888000	usd
CY2023Q1	amrs	Finance Lease Liability To Be Paid After Year Four FinanceLeaseLiabilityToBePaidAfterYearFour	0	usd
CY2023Q1	amrs	Lessee Operating Lease Liability To Be Paid After Year Four LesseeOperatingLeaseLiabilityToBePaidAfterYearFour	222233000	usd
CY2023Q1	amrs	Lease Liability Payments Due After Year Four LeaseLiabilityPaymentsDueAfterYearFour	222233000	usd
CY2023Q1	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	74000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	334928000	usd
CY2023Q1	amrs	Lease Liability Payment Due LeaseLiabilityPaymentDue	335002000	usd
CY2023Q1	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	16000	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	241458000	usd
CY2023Q1	amrs	Lease Liability Undiscounted Excess Amount LeaseLiabilityUndiscountedExcessAmount	241474000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	58000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	93470000	usd
CY2023Q1	amrs	Operating And Finance Lease Liabilities OperatingAndFinanceLeaseLiabilities	93528000	usd
CY2023Q1	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	14000	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2484000	usd
CY2023Q1	amrs	Operating And Finance Lease Liabilities Current OperatingAndFinanceLeaseLiabilitiesCurrent	2498000	usd
CY2023Q1	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	44000	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	90986000	usd
CY2023Q1	amrs	Operating And Finance Lease Liabilities Noncurrent OperatingAndFinanceLeaseLiabilitiesNoncurrent	91030000	usd
CY2023Q1	us-gaap	Finance Lease Liability FinanceLeaseLiability	58000	usd
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	93470000	usd
CY2023Q1	amrs	Operating And Finance Lease Liabilities OperatingAndFinanceLeaseLiabilities	93528000	usd
CY2023Q1	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	7892000	usd
CY2022Q4	us-gaap	Equity Securities Fvni Noncurrent EquitySecuritiesFVNINoncurrent	7892000	usd
CY2023Q1	us-gaap	Equity Method Investments EquityMethodInvestments	3000000	usd
CY2022Q4	us-gaap	Equity Method Investments EquityMethodInvestments	3000000	usd
CY2023Q1	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	531000	usd
CY2022Q4	us-gaap	Deposits Assets Noncurrent DepositsAssetsNoncurrent	530000	usd
CY2023Q1	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	0	usd
CY2022Q4	us-gaap	Receivables Fair Value Disclosure ReceivablesFairValueDisclosure	671000	usd
CY2023Q1	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	2239000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	1811000	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13662000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13904000	usd
CY2023Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	23308000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	18795000	usd
CY2023Q1	us-gaap	Interest Payable Current InterestPayableCurrent	19212000	usd
CY2022Q4	us-gaap	Interest Payable Current InterestPayableCurrent	14639000	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4216000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	4826000	usd
CY2023Q1	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	3872000	usd
CY2022Q4	us-gaap	Asset Retirement Obligation Current AssetRetirementObligationCurrent	3763000	usd
CY2023Q1	amrs	Contract Termination Liability Current ContractTerminationLiabilityCurrent	1379000	usd
CY2022Q4	amrs	Contract Termination Liability Current ContractTerminationLiabilityCurrent	1369000	usd
CY2023Q1	amrs	License Fee Payable Current LicenseFeePayableCurrent	1050000	usd
CY2022Q4	amrs	License Fee Payable Current LicenseFeePayableCurrent	1050000	usd
CY2023Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	0	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	829000	usd
CY2023Q1	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	11031000	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	9136000	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	81068000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	73565000	usd
CY2023Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	882100000	usd
CY2022Q4	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	839000000	usd
CY2023Q1	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	469800000	usd
CY2022Q4	us-gaap	Debt Instrument Fair Value DebtInstrumentFairValue	331600000	usd
CY2023Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	962026000	usd
CY2023Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	29920000	usd
CY2023Q1	amrs	Debt Change In Fair Value Gain Loss DebtChangeInFairValueGainLoss	8839000	usd
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	940945000	usd
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	923047000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	33989000	usd
CY2022Q4	amrs	Debt Change In Fair Value Gain Loss DebtChangeInFairValueGainLoss	3985000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	893043000	usd
CY2023Q1	amrs	Long Term Debt Current Maturities Including Due To Related Parties Principal LongTermDebtCurrentMaturitiesIncludingDueToRelatedPartiesPrincipal	188811000	usd
CY2023Q1	amrs	Long Term Debt Current Maturities Including Due To Related Parties Unaccreted Debt Discount LongTermDebtCurrentMaturitiesIncludingDueToRelatedPartiesUnaccretedDebtDiscount	10522000	usd
CY2023Q1	amrs	Long Term Debt Current Maturities Including Due To Related Parties Change In Fair Value LongTermDebtCurrentMaturitiesIncludingDueToRelatedPartiesChangeInFairValue	8839000	usd
CY2023Q1	amrs	Long Term Debt Current Maturities Including Due To Related Parties LongTermDebtCurrentMaturitiesIncludingDueToRelatedParties	187128000	usd
CY2022Q4	amrs	Long Term Debt Current Maturities Including Due To Related Parties Principal LongTermDebtCurrentMaturitiesIncludingDueToRelatedPartiesPrincipal	128708000	usd
CY2022Q4	amrs	Long Term Debt Current Maturities Including Due To Related Parties Unaccreted Debt Discount LongTermDebtCurrentMaturitiesIncludingDueToRelatedPartiesUnaccretedDebtDiscount	11891000	usd
CY2022Q4	amrs	Long Term Debt Current Maturities Including Due To Related Parties Change In Fair Value LongTermDebtCurrentMaturitiesIncludingDueToRelatedPartiesChangeInFairValue	3985000	usd
CY2022Q4	amrs	Long Term Debt Current Maturities Including Due To Related Parties LongTermDebtCurrentMaturitiesIncludingDueToRelatedParties	120802000	usd
CY2023Q1	amrs	Long Term Debt Excluding Current Maturities Including Due To Related Parties Principal LongTermDebtExcludingCurrentMaturitiesIncludingDueToRelatedPartiesPrincipal	773215000	usd
CY2023Q1	amrs	Long Term Debt Excluding Current Maturities Including Due To Related Parties Unaccreted Debt Discount LongTermDebtExcludingCurrentMaturitiesIncludingDueToRelatedPartiesUnaccretedDebtDiscount	19398000	usd
CY2023Q1	amrs	Long Term Debt Excluding Current Maturities Including Due To Related Parties Change In Fair Value LongTermDebtExcludingCurrentMaturitiesIncludingDueToRelatedPartiesChangeInFairValue	0	usd
CY2023Q1	amrs	Long Term Debt Excluding Current Maturities Including Due To Related Parties LongTermDebtExcludingCurrentMaturitiesIncludingDueToRelatedParties	753817000	usd
CY2022Q4	amrs	Long Term Debt Excluding Current Maturities Including Due To Related Parties Principal LongTermDebtExcludingCurrentMaturitiesIncludingDueToRelatedPartiesPrincipal	794339000	usd
CY2022Q4	amrs	Long Term Debt Excluding Current Maturities Including Due To Related Parties Unaccreted Debt Discount LongTermDebtExcludingCurrentMaturitiesIncludingDueToRelatedPartiesUnaccretedDebtDiscount	22098000	usd
CY2022Q4	amrs	Long Term Debt Excluding Current Maturities Including Due To Related Parties Change In Fair Value LongTermDebtExcludingCurrentMaturitiesIncludingDueToRelatedPartiesChangeInFairValue	0	usd
CY2022Q4	amrs	Long Term Debt Excluding Current Maturities Including Due To Related Parties LongTermDebtExcludingCurrentMaturitiesIncludingDueToRelatedParties	772241000	usd
CY2023Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	7586000	usd
CY2022Q1	us-gaap	Interest Expense Debt Excluding Amortization InterestExpenseDebtExcludingAmortization	3415000	usd
CY2023Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	5068000	usd
CY2022Q1	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	962000	usd
CY2023Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	12654000	usd
CY2022Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	4377000	usd
CY2023Q1	us-gaap	Accretion Expense AccretionExpense	329000	usd
CY2022Q1	us-gaap	Accretion Expense AccretionExpense	886000	usd
CY2023Q1	us-gaap	Interest Expense InterestExpense	12983000	usd
CY2022Q1	us-gaap	Interest Expense InterestExpense	5263000	usd
CY2023Q1	amrs	Long Term Debt Future Minimum Payments Remainder Of The Year LongTermDebtFutureMinimumPaymentsRemainderOfTheYear	205823000	usd
CY2023Q1	amrs	Long Term Debt Future Minimum Payments Year One LongTermDebtFutureMinimumPaymentsYearOne	101466000	usd
CY2023Q1	amrs	Long Term Debt Future Minimum Payments Due Year Two LongTermDebtFutureMinimumPaymentsDueYearTwo	40697000	usd
CY2023Q1	amrs	Long Term Debt Future Minimum Payments Due Year Three LongTermDebtFutureMinimumPaymentsDueYearThree	700379000	usd
CY2023Q1	amrs	Long Term Debt Future Minimum Payments Due Year Four LongTermDebtFutureMinimumPaymentsDueYearFour	0	usd
CY2023Q1	amrs	Long Term Debt Future Minimum Payments Due After Four Years LongTermDebtFutureMinimumPaymentsDueAfterFourYears	0	usd
CY2023Q1	amrs	Long Term Debt Future Minimum Payments Due LongTermDebtFutureMinimumPaymentsDue	1048365000	usd
CY2023Q1	amrs	Debt Future Minimum Payments Interest Included In Payments DebtFutureMinimumPaymentsInterestIncludedInPayments	81768000	usd
CY2023Q1	amrs	Debt Future Minimum Payments Interest Accruals To Be Converted To Principal Included In Payments DebtFutureMinimumPaymentsInterestAccrualsToBeConvertedToPrincipalIncludedInPayments	4571000	usd
CY2023Q1	amrs	Debt Future Minimum Payments Present Value Of Net Minimum Payments DebtFutureMinimumPaymentsPresentValueOfNetMinimumPayments	962026000	usd
CY2023Q1	amrs	Debt Future Minimum Payments Present Value Of Net Minimum Payments Current Maturities DebtFutureMinimumPaymentsPresentValueOfNetMinimumPaymentsCurrentMaturities	188811000	usd
CY2023Q1	amrs	Debt Future Minimum Payments Present Value Of Net Minimum Payments Noncurrent DebtFutureMinimumPaymentsPresentValueOfNetMinimumPaymentsNoncurrent	773215000	usd
CY2022Q4	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	28692646	shares
CY2023Q1	amrs	Class Of Warrant Or Right Additional Warrants Issued ClassOfWarrantOrRightAdditionalWarrantsIssued	0	shares
CY2023Q1	amrs	Class Of Warrant Or Right Exercised ClassOfWarrantOrRightExercised	0	shares
CY2023Q1	amrs	Class Of Warrant Or Right Expired ClassOfWarrantOrRightExpired	0	shares
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	28692646	shares
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-193342000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-107305000	usd
CY2023Q1	amrs	Dilutive Securities Effect On Basic Earnings Dilutive Convertible Debt Interest DilutiveSecuritiesEffectOnBasicEarningsDilutiveConvertibleDebtInterest	0	usd
CY2022Q1	amrs	Dilutive Securities Effect On Basic Earnings Dilutive Convertible Debt Interest DilutiveSecuritiesEffectOnBasicEarningsDilutiveConvertibleDebtInterest	457000	usd
CY2023Q1	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	0	usd
CY2022Q1	us-gaap	Debt Securities Gain Loss DebtSecuritiesGainLoss	-12650000	usd
CY2023Q1	amrs	Dilutive Securities Effect On Basic Earnings Change In Fair Value Of Derivative Instruments DilutiveSecuritiesEffectOnBasicEarningsChangeInFairValueOfDerivativeInstruments	0	usd
CY2022Q1	amrs	Dilutive Securities Effect On Basic Earnings Change In Fair Value Of Derivative Instruments DilutiveSecuritiesEffectOnBasicEarningsChangeInFairValueOfDerivativeInstruments	-1815000	usd
CY2023Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-193342000	usd
CY2022Q1	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-121313000	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	365603738	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	312896452	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.53
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.34
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	365603738	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	312896452	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Conversion Of Debt Securities IncrementalCommonSharesAttributableToConversionOfDebtSecurities	10146017	shares
CY2023Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	0	shares
CY2022Q1	us-gaap	Incremental Common Shares Attributable To Call Options And Warrants IncrementalCommonSharesAttributableToCallOptionsAndWarrants	669213	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	365603738	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	323711682	shares
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.53
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	155701332	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	112000167	shares
CY2023Q1	us-gaap	Loss Contingency Disclosures LossContingencyDisclosures	Commitments and ContingenciesGuarantor Arrangements<div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has agreements whereby it indemnifies its executive officers and directors for certain events or occurrences while the executive officer or director is serving in his or her official capacity. The indemnification period remains enforceable for the executive officer's or director’s lifetime. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a director and officer insurance policy that limits its exposure and enables the Company to recover a portion of any future payments. As a result of its insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal and had no liabilities recorded for these agreements as of March 31, 2023 and December 31, 2022.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Foris Convertible Note and the Perrara Bridge Loan are collateralized by first-priority liens on substantially all of the Company's assets, including Company intellectual property, other than certain Company intellectual property licensed to DSM, the Company's international subsidiaries, and the Company's ownership interests in joint ventures. Certain of the Company’s subsidiaries have guaranteed the Company’s obligations under the Foris Convertible Note.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The obligations under the DSM Term Loan are guaranteed by certain of the Company's subsidiaries, and secured by a perfected security interest in certain payment obligations due to the Company from DSM Nutritional Products Ltd., as well as a pledge of the Company’s equity interest in RealSweet LLC.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2021, the Company entered into a 10-year manufacturing partnership agreement with Renfield Manufacturing, LLC (Renfield) to provide manufacturing services and third-party logistics processes, including inventory management, warehousing, and fulfillment for certain of the Company’s consumer product lines. On September 22, 2022, Renfield notified the Company that it was terminating the Manufacturing and Fulfillment Agreement and the Right of First Refusal Agreement due to failure to pay certain amounts due to Renfield. The Company disputes Renfield's allegations and the purported termination of the two agreements. The Company also provided a $0.5 million letter of credit and guarantee to the lessor of the Renfield manufacturing facility, which extends through August 2032. If Renfield fails to perform under the facility lease, the Company can terminate the manufacturing agreement. The Company expects that its potential future performance under the guarantee is not probable of occurrence. Accordingly, the Company had no liabilities recorded for the guarantee as of March 31, 2023 and December 31, 2022. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Matters</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Certain conditions may exist as of the date the financial statements are issued, which may result in a loss to the Company but will only be recorded when one or more future events occur or fail to occur. The Company's management assesses such contingent liabilities, and such assessment inherently involves an exercise of judgement. In assessing loss contingencies related to legal proceedings that are pending against and by the Company or unasserted claims that may result in such proceedings, the Company's management evaluates the perceived merits of any legal proceedings or unasserted claims as well as the perceived merits of the amount of relief sought or expected to be sought.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">If the assessment of a contingency indicates that it is probable that a material loss has been incurred and the amount of the liability can be estimated, then the estimated liability would be accrued in the Company's financial statements. If the assessment indicates that a potential material loss contingency is not probable but is reasonably possible, or is probable but cannot be reasonably estimated, then the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed. Loss contingencies considered to be remote by management are generally not disclosed unless they involve guarantees, in which case the guarantee would be disclosed.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Subsequent to the filing of the securities class action complaint described above, on June 21, 2019 and October 1, 2019, respectively, two separate purported shareholder derivative complaints were filed in the U.S. District Court for the Northern District of California (Bonner v. Doerr, et al., and Carlson v. Doerr, et al.) based on similar allegations to those made in the securities class action complaint and naming the Company, and certain of the Company’s current and former officers and directors, as defendants. The derivative lawsuits sought to recover, on the Company’s behalf, unspecified damages purportedly sustained by the Company in connection with allegedly misleading statements and omissions made in connection with the Company’s securities filings. An additional shareholder derivative complaint (Kimbrough v. Melo, et al.), substantially identical to the Bonner complaint, was filed on December 18, 2020 in the U.S. District Court for the Northern District of California. By agreement, the Kimbrough and Bonner complaints were consolidated for all purposes on April 9, 2021. On June 20, 2022, the Court granted the Company's motion to dismiss Bonner's amended complaint without prejudice. Subsequently, Bonner informed the Court that it did not intend to file a second amended complaint. On August 18, 2022, the Court issued the judgment in favor of the Company and awarded the Company an immaterial amount in costs. On September 9, 2022, Bonner filed a notice of appeal of the Court's decision.</span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On August 23, 2020, Lavvan, Inc. (Lavvan) brought claims in arbitration against the Company under that certain Research, Collaboration, and License Agreement dated March 18, 2019, as amended (RCLA), and on September 10, 2020, Lavvan filed a </span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">suit against the Company in the U.S. District Court for the Southern District of New York (SDNY). The evidentiary hearing took place in arbitration from October 24 through 28, 2022. Both the arbitration and SDNY proceedings are currently pending, and it is not yet possible to reliably determine any potential liability that could result therefrom. The Company believes Lavvan's claims lack merit and intends to continue to defe</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">nd itself vigorously. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On October 11, 2022, AO Representative Expense Fund LLC (AO), on behalf of former shareholders of Olika Inc. (Olika), a company acquired by the Company on August 9, 2021 through a merger, filed a complaint against the Company in New York State court. AO alleged that, in breach of the merger agreement, the Company undertook certain actions with the intent of avoiding payment of earnouts to the former shareholders of Olika. On January 26, 2022, the Company filed its motion to dismiss the complaint, which was amended by AO on March 22, 2023. The Company filed its motion to dismiss the amended complaint on April 26, 2023. T</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">he Company believes AO’s claims lack merit and intends to continue to defend itself vigorously.</span></div><div><span><br/></span></div><div><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On February 22, 2023, Disruptional Ltd. and & Vest Beauty Labs LP, sellers of Beauty Labs International Ltd., a business acquired by the Company on August 31, 2021, filed a complaint against the Company in New York State court, alleging, among other things, a breach of contract related to earnout payments. The Company believes the Sellers’ claims lack merit and intends to defend itself vigorously.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">On March 24, 2023, Park Wynwood LLC (Wynwood), the landlord for one of the Company’s leasehold properties in Miami, Florida, filed a complaint in the Superior Court of the State of California for the County of San Francisco, alleging a breach of the terms of the lease relating to tenant improvements. Wynwood is seeking damages, including acceleration of rent payments. </span></div><div style="text-align:justify;text-indent:24.75pt"><span><br/></span></div><div style="text-align:justify"><span style="background-color:#ffffff;color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">The Company is subject to disputes and claims that arise or have arisen in the ordinary course of business and that have not resulted in legal proceedings or have not been fully adjudicated. Such matters that may arise in the ordinary course of business are subject to many uncertainties and outcomes, and are not predictable with reasonable assurance and therefore an estimate of all the reasonably possible losses cannot be determined at this time. Therefore, if one or more of these legal disputes or claims resulted in settlements or legal proceedings that were resolved against the Company for amounts in excess of management’s expectations, the Company’s consolidated financial statements for the relevant reporting period could be materially adversely affected.</span></div>
CY2023Q1	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Net LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityNet	0	usd
CY2022Q4	us-gaap	Liabilities For Guarantees On Long Duration Contracts Guaranteed Benefit Liability Net LiabilitiesForGuaranteesOnLongDurationContractsGuaranteedBenefitLiabilityNet	0	usd
	us-gaap	Loss Contingency New Claims Filed Number LossContingencyNewClaimsFiledNumber	2	complaint
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	56083000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	57709000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	56083000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	57709000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	56083000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	57709000	usd
CY2023Q1	amrs	Accounts Receivable Net Current Excluding Related Parties AccountsReceivableNetCurrentExcludingRelatedParties	36842000	usd
CY2022Q4	amrs	Accounts Receivable Net Current Excluding Related Parties AccountsReceivableNetCurrentExcludingRelatedParties	45775000	usd
CY2023Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	10836000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	6608000	usd
CY2023Q1	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	3872000	usd
CY2022Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	806000	usd
CY2023Q1	amrs	Contract With Customer Asset Related Party After Allowance For Credit Loss Current ContractWithCustomerAssetRelatedPartyAfterAllowanceForCreditLossCurrent	33679000	usd
CY2022Q4	amrs	Contract With Customer Asset Related Party After Allowance For Credit Loss Current ContractWithCustomerAssetRelatedPartyAfterAllowanceForCreditLossCurrent	36638000	usd
CY2023Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	33000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	26000	usd
CY2023Q1	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	10836000	usd
CY2022Q4	us-gaap	Accounts Receivable Related Parties Current AccountsReceivableRelatedPartiesCurrent	6608000	usd
CY2023Q1	amrs	Contract With Customer Asset Related Party After Allowance For Credit Loss Current ContractWithCustomerAssetRelatedPartyAfterAllowanceForCreditLossCurrent	33679000	usd
CY2022Q4	amrs	Contract With Customer Asset Related Party After Allowance For Credit Loss Current ContractWithCustomerAssetRelatedPartyAfterAllowanceForCreditLossCurrent	36638000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4504430	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.72
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y4M24D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	48488	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.62
CY2023Q1	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	0	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	450210	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	5.09
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	4102708	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.84
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y2M12D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	22000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	3905495	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	6.99
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P7Y1M6D
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	2000	usd
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	2032792	shares
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	9.60
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P5Y7M6D
CY2023Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q1	amrs	Asset Purchase Agreement Consideration Transferred Contingent Consideration Earn Out Payments Period AssetPurchaseAgreementConsiderationTransferredContingentConsiderationEarnOutPaymentsPeriod	P3Y
CY2023Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5785000	usd
CY2022Q1	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11588000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	89700000	usd
CY2023Q1	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P2Y7M6D
CY2023Q1	amrs	Payments For Asset Purchase Agreement PaymentsForAssetPurchaseAgreement	200000000	usd
CY2023Q1	amrs	Asset Purchase Agreement Consideration Transferred Contingent Consideration AssetPurchaseAgreementConsiderationTransferredContingentConsideration	150000000	usd

Files In Submission

Name	View Source	Status
amrs-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
amrs-20230331_cal.xml	Edgar Link	unprocessable
amrs-20230331_pre.xml	Edgar Link	unprocessable
amrs-20230331_def.xml	Edgar Link	unprocessable
0001365916-23-000060-index-headers.html	Edgar Link	pending
0001365916-23-000060-index.html	Edgar Link	pending
0001365916-23-000060.txt	Edgar Link	pending
0001365916-23-000060-xbrl.zip	Edgar Link	pending
amrs-20230331.htm	Edgar Link	pending
amrs-20230331.xsd	Edgar Link	pending
exhibit1002-givaudanassetp.htm	Edgar Link	pending
exhibit1003-firstamendment.htm	Edgar Link	pending
exhibit1004-secondamendmen.htm	Edgar Link	pending
exhibit31012023q1.htm	Edgar Link	pending
exhibit31022023q1.htm	Edgar Link	pending
exhibit32012023q1.htm	Edgar Link	pending
exhibit32022023q1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
amrs-20230331_htm.xml	Edgar Link	completed
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

AMYRIS, INC.

2023 Q2 Form 10-Q Financial Statement

#000136591623000060 Filed on May 10, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission